Genoway

Genoway

ALGEN · PA · Healthcare / Biotechnology

2.00EUR-0.03 (-1.48%)

Price History

Full chart

Market Stats

Previous Close2.03
Open2.00
Day Range2.00 – 2.00
52-Week Range2.09 – 3.07
Volume1.41K
Market Cap27.14M
P/E (TTM)0.00
Forward P/E0.00
EPS-0.14
Dividend Yield0.00%
Beta0.37
50-Day Avg2.45
200-Day Avg2.45

About

genOway Société anonyme, a biotechnology company, engages in the development and commercialization of custom genetically modified mouse, rat, and cell line models worldwide. It produces customized mouse models, such as knockout (KO) and knockin (KI) mouse models; customized rat models, including constitutive and conditional KO, point mutation KI, and quick KI rat models; and customized cell lines, such as constitutive and inducible KO, point mutation KI, reporter KI, quick KI, and KI cell lines. The company also offers humanized immune checkpoint mouse models; immunodeficient and reconstituted mouse and rat strains models; humanized immune target models; other mouse and rat catalog models; and cell lines. It serves pharmaceutical and life science companies, and academic institutes. The company was incorporated in 1999 and is based in Lyon, France.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEODr. Alexandre Fraichard
  • Employees0
  • HeadquartersTechnopark 2, Lyon, France, 69007, France
  • Websitehttps://www.genoway.com

Leadership

  • Dr. Alexandre FraichardFounder, GM & Director

Financials

Income Statement

Currency: EUR2004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue1.58M2.17M3.49M4.82M6.74M6.61M7.34M7.74M8.74M9.85M9.63M10.13M11.54M13.16M14.95M14.28M11.02M14.02M17.05M20.05M22.06M20.96M
Growth (%)-+37.51%+60.87%+37.91%+39.92%-1.87%+11.04%+5.41%+12.87%+12.68%-2.15%+5.16%+13.89%+14.09%+13.59%-4.51%-22.85%+27.26%+21.64%+17.55%+10.04%-5.00%
Cost of Revenue4.72M5.79M6.28M7.83M9.06M4.21M3.85M945.29K1.25M4.79M4.17M4.26M4.95M5.79M6.34M6.12M13.98M17.77M18.36M1.24M12.81M10.71M
Gross Profit-3.14M-3.62M-2.79M-3.01M-2.32M2.41M3.49M6.80M7.49M5.05M5.46M5.87M6.58M7.38M8.61M8.16M-2.96M-3.75M-1.31M18.80M-1.89M10.25M
Gross Margin-199.00%-166.68%-79.93%-62.56%-34.41%36.40%47.53%87.79%85.74%51.33%56.73%57.99%57.05%56.05%57.58%57.14%-26.87%-26.72%-7.68%93.80%-8.55%48.90%
Operating Expense105.54K-32.65K196.71K168.08K300.55K2.03M2.78M6.44M7.93M4.88M5.21M5.49M5.89M6.62M8.03M8.73M878.80K848.38K-2.26M16.74M-3.70M9.58M
Operating Income-3.25M-3.59M-2.99M-3.18M-2.62M376.39K713.58K359.42K-439.76K173.63K251.60K381.62K691.91K753.78K579.80K-575.13K-3.84M-4.59M949.84K2.07M1.81M669.36K
Operating Margin-205.68%-165.18%-85.56%-66.05%-38.87%5.69%9.72%4.64%-5.03%1.76%2.61%3.77%6.00%5.73%3.88%-4.03%-34.85%-32.78%5.57%10.30%8.21%3.19%
EBITDA-2.77M-3.32M-2.72M-2.90M-2.33M759.55K1.26M800.41K452.05K794.05K1.19M1.13M1.02M186.69K-1.12M605.14K-2.57M-1.88M536.79K6.35M3.89M4.96M
EBITDA Margin-175.74%-153.13%-77.80%-60.20%-34.51%11.48%17.13%10.34%5.17%8.07%12.38%11.11%8.81%1.42%-7.50%4.24%-23.30%-13.40%3.15%31.68%17.65%23.69%
Net Income-2.78M-3.47M-2.43M-1.09M-1.16M116.68K561.09K502.33K-352.11K261.04K26.58K38.39K582.23K1.93M571.65K-1.04M-687.30K-322.60K777.75K1.57M1.83M928.00K
Net Income Margin-175.83%-159.69%-69.61%-22.62%-17.28%1.76%7.64%6.49%-4.03%2.65%0.28%0.38%5.05%14.67%3.82%-7.26%-6.24%-2.30%4.56%7.82%8.30%4.43%
Interest Expense040.20K48.78K0085.37K298.07K259.85K183.66K0243.79K345.02K124.49K154.57K448.51K246.18K173.05K274.72K122.03K109.07K146.51K307.57K
Interest Expense % of Total Revenue0.00%1.85%1.40%0.00%0.00%1.29%4.06%3.36%2.10%0.00%2.53%3.41%1.08%1.17%3.00%1.72%1.57%1.96%0.72%0.54%0.66%1.47%

Balance Sheet

Currency: EUR2004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets5.41M4.40M7.07M10.29M10.21M11.17M11.43M11.01M10.54M9.75M10.38M10.78M11.70M17.17M19.69M19.15M27.57M32.50M32.92M31.84M31.80M45.35M
Total Liabilities2.06M2.46M5.37M4.81M5.79M7.35M6.83M5.78M5.70M4.64M5.23M6.10M6.44M9.98M11.80M12.31M18.57M17.94M16.76M14.46M13.23M20.38M
Total Equity1.90M-1.57M98.30K4.56M3.38M3.82M4.60M5.23M4.84M4.99M5.15M4.68M5.26M7.19M7.89M6.84M9.00M14.72M16.17M17.38M18.57M24.97M
Cash2.20M1.16M97.00K5.33M2.60M4.57M5.57M6.12M4.01M4.55M3.81M3.79M2.64M3.95M3.05M1.09M2.72M5.61M4.88M4.26M4.95M549.29K
Total Debt1.76K31.14K37.77K258.46K4.07K4.68K7.63K4.42K38.12K6.30K205.53K12.35K10.68K4.18M4.67M6.02M10.77M10.83M9.05M7.23M5.58M13.77M
Net Debt1.76K31.14K37.77K258.46K4.07K-4.57M-5.56M-6.11M-3.98M-4.54M-3.61M-3.78M-2.63M-202.16K1.62M4.93M8.05M5.22M4.17M2.97M622.98K13.22M

Cash Flow

Currency: EUR2004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow---1.42M-1.35M-1.80M914.07K741.51K-1.70M852.87K200.29K851.08K-901.83K620.94K847.03K1.18M-164.33K-561.34K2.36M3.06M5.38M-1.43M
Investing Cash Flow---103.03K-411.24K--37.99K-331.19K-326.76K-394.22K-111.15K-1.19M-176.92K-241.74K-4.75M-4.75M-4.75M-4.75M-2.26M-1.94M-2.00M-2.86M-11.32M
Financing Cash Flow4.79M2.00M2.00M5.26M118.00K-95.05K211.81K132.65K-42.00K-176.38K112.27K-507.07K06.54M6.54M6.54M6.54M5.71M-1.14M-1.69M-1.83M14.84M
Capital Expenditure265.00K104.00K257.73K308.69K405.00K4.98K357.19K254.35K405.19K100.41K47.66K161.06K254.52K2.70M2.70M2.70M4.52M2.28M1.92M1.78M2.39M10.93M
Free Cash Flow---1.68M-1.66M-1.80M556.89K487.15K-2.10M752.46K152.63K690.02K-1.16M620.94K847.03K1.18M-4.68M-2.84M438.60K1.28M2.99M-12.35M
FCF to OCF--118.16%122.82%-99.72%60.92%65.70%123.85%88.23%76.21%81.08%128.22%100.00%100.00%100.00%2848.85%505.39%18.62%41.79%55.64%866.42%

Earnings

Report DateSep 30, 2013Mar 31, 2014Sep 29, 2014Mar 30, 2015Jun 13, 2016Sep 12, 2016May 9, 2017Sep 14, 2017May 9, 2018Sep 21, 2018Jun 10, 2019Oct 10, 2019May 14, 2020Sep 17, 2020Jun 23, 2021Sep 27, 2021Jul 18, 2022Oct 17, 2022Apr 29, 2025Sep 24, 2025
EPS Estimate0.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.00
EPS Actual0.000.000.000.000.000.030.070.270.060.060.04-0.18-0.18-0.170.04-0.080.040.020.000.00
Surprise--------------------
Timing--------------------

Key Statistics & Ratios

Market Cap27.14M
Enterprise Value36.33M
Trailing P/E0.00
Forward P/E0.00
PEG Ratio0.00
Price / Sales1.04
Price / Book1.19
EPS-0.14
Book Value1.83
Revenue (TTM)26.03M
Gross Profit (TTM)12.76M
EBITDA4.43M
Profit Margin3.56%
Operating Margin9.28%
Return on Equity4.26%
Return on Assets2.06%
Shares Outstanding12.34M
Shares Float0
Beta0.37
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%